Fineotex Chemical Limited (FCL) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Fineotex Chemical Limited ₹7.38, price ₹56.81, upside -87.0%, quality 34 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Fineotex Chemical Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹8.40 – ₹15,378 · fair‑value band ₹6.35 – ₹13.46 · the ₹56.81 price screens above the ₹7.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Fineotex Chemical in your weekly email
Every Wednesday you see whether Fineotex Chemical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Fineotex Chemical Limited manufactures and sells textile chemicals, auxiliaries, and specialty chemicals in India and United States.
Show more
Fineotex Chemical Limited manufactures and sells textile chemicals, auxiliaries, and specialty chemicals in India and United States. The company provides textile chemicals for pre-treatment, dyeing, printing, and finishing processes, as well as enzymes; water treatment chemicals; and oilfield chemicals, such as drilling fluids, cementing fluids, production chemicals, and fracturing solutions. It also offers cleaning and hygiene products, including disinfection, housekeeping, kitchen and personal care, and laundry products. The company's products are used in textile, home care, hygiene, mining, garment, water treatment, leather, construction, paint, agrochemicals, and adhesives sectors. It also exports its products. The company was founded in 1979 and is based in Mumbai, India.
Stock analysis
Fineotex Chemical Limited (FCL) currently trades at ₹56.81, while our model-based Fair Value estimate is ₹7.38, implying the stock looks roughly 669.8% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹29.46 per share, and 0 of the 17 models we run sit above the ₹56.81 price.
Bear case: the Dividend Discount group reads lowest at ₹1.55, and 17 of the 17 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹6.35 (bear) to ₹13.46 (bull), the price of ₹56.81 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Fineotex Chemical Limited reported revenue of ₹7.7B in FY2026 versus ₹3.7B in FY2022, a compound +20.5%/yr. Reported net income was ₹1.1B in FY2026, compounding +18.5%/yr from FY2022.
Key figures
Market cap ₹56.7B (≈ $589M) · P/E ratio 52.1 · P/S ratio 7.34 · EPS (TTM) ₹1.09 · Dividend yield 0.2% · Net margin 14.1% · Return on equity 14.9% · Return on assets (EBIT) 21.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (medium confidence).
What moves the price
The share trades about 3% below its 52-week high and 195% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −87%, FCL screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (₹1.55 to ₹44.29). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ₹6.35Fair Value ₹7.38Bull ₹13.46
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.4704 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+44.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.9%
Start year 2021 (pandemic). Over 10 years: +21.7% a year
Revenue growth 19 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+41.9%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−22.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−22.3%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−22% vs −3%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 16%
Compare Fineotex Chemical Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score34 · Bottom 25%
Fair Value upside−87% · Bottom 25%
Profitability
Return on equity (TTM)15% · Top 25%
Return on assets8% · Top 25%
Net margin (TTM)14% · Top 25%
Operating margin (TTM)13% · Above median
Growth and dividend
Revenue growth162% · Top 25%
Dividend yield (TTM)0.2% · Bottom 25%
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)52.1× · Priciest 25%
P/B6.42× · Priciest 25%
P/S (TTM)7.34× · Priciest 25%
EV/EBITDA41.8× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 21
PAST (return on equity)60· sector 23
HEALTH (low debt)100· sector 95
DIVIDEND (yield)4· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Fineotex Chemical Limited Fair Value". https://www.fairvalue-calculator.com/stock/FCL
Frequently asked questions
Is Fineotex Chemical Limited (FCL) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹7.38 versus a price of ₹56.81, about −87% upside (overvalued).
What is the fair value of FCL?
Our model-based fair value for Fineotex Chemical Limited is ₹7.38 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹56.81.
What is the quality score of FCL?
Fineotex Chemical Limited has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Fineotex Chemical Limited (FCL)?
Our model-based price target is the fair value of ₹7.38 (as of Sep 24, 2026) from 17 valuation models. Cautious scenario ₹6.35, optimistic scenario ₹13.46. It is a calculation from audited fundamentals, not an analyst target.
What is the Fineotex Chemical Limited stock forecast for 2026?
Our models put fair value at ₹7.38, about −87% upside versus a price of ₹56.81 (overvalued). Cautious scenario ₹6.35, optimistic scenario ₹13.46. The calculation is refreshed regularly with new filings.
What is the revenue of Fineotex Chemical Limited (FCL)?
Fineotex Chemical Limited reported trailing-twelve-month revenue of about ₹7.7B (latest available figure, as of Sep 24, 2026).
Does Fineotex Chemical Limited pay a dividend?
Fineotex Chemical Limited currently shows a dividend yield of about 0.21% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Fineotex Chemical Limited (FCL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Fineotex Chemical Limited it is ₹7.38 per share (as of Sep 24, 2026), against a price of ₹56.81. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Fineotex Chemical Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, FCL trades above its calculated fair value: price ₹56.81, fair value ₹7.38, a gap of about −87% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FCL?
No. The price is what the market pays today (₹56.81); the fair value is what the company's own numbers justify (₹7.38). For Fineotex Chemical Limited the two are ₹49.43 per share apart. That gap is exactly why we show both numbers side by side.
How much is Fineotex Chemical Limited worth?
The market values Fineotex Chemical Limited at about ₹56.7B (market capitalisation, as of Sep 24, 2026). Per share that is ₹56.81; our models calculate a fair value of ₹7.38 per share.
What do the bullish and bearish scenarios say about FCL?
Our models span a range for Fineotex Chemical Limited: cautious scenario ₹6.35, base ₹7.38, optimistic ₹13.46 per share (as of Sep 24, 2026, price ₹56.81). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of FCL?
Fineotex Chemical Limited trades at a price-to-earnings ratio of 52.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹7.38 is built from several models across several years. Other multiples: P/B 6.4, P/S 7.3, EV/EBITDA 41.8.
How solid is the balance sheet of Fineotex Chemical Limited (FCL)?
Balance-sheet figures for Fineotex Chemical Limited (as of Sep 24, 2026): return on equity 14.9%, debt of 0.00 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is FCL from its 52-week high?
Fineotex Chemical Limited trades at ₹56.81, about 3% below its 52-week high of ₹58.71 and 195% above the low of ₹19.24 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of ₹7.38 is for.
Which stocks are comparable to Fineotex Chemical Limited?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Fineotex Chemical Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹56.81, calculated fair value ₹7.38 (−87%), Quality Score 34/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FCL calculated?
We run Fineotex Chemical Limited through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹7.38, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Fineotex Chemical Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Fineotex Chemical Limited (FCL)?
The closing price on Sep 23, 2026 was ₹56.81. Our model-based fair value is ₹7.38, about −87% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Fineotex Chemical Limited right now?
The price sits above even our optimistic bull case (₹13.46). The favourable scenario is already priced in. Weak quality (34/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (₹6.35 to ₹13.46) leaves room in how you read the outcome.
Where does the earnings growth of Fineotex Chemical Limited (FCL) come from?
Earnings per share at Fineotex Chemical Limited grew +6.9 % a year from 2015 to 2026. Broken into its drivers: revenue per share +4.8 %, EBIT margin −0.6 %, tax rate +1.5 %, residual (interest, one-offs) +1.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Fineotex Chemical Limited
How large is the market capitalisation of Fineotex Chemical Limited (FCL)?
The market capitalisation of Fineotex Chemical Limited is ₹56.7B (≈ $589M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Fineotex Chemical Limited (FCL)?
The price-to-sales ratio of Fineotex Chemical Limited is 7.34 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Fineotex Chemical Limited (FCL)?
Earnings per share at Fineotex Chemical Limited are ₹1.09 (price ÷ EPS = P/E 52.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Fineotex Chemical Limited (FCL)?
The dividend yield of Fineotex Chemical Limited is 0.2% (payout 11.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Fineotex Chemical Limited (FCL)?
The net margin of Fineotex Chemical Limited is 14.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Fineotex Chemical Limited (FCL)?
The return on equity (ROE) of Fineotex Chemical Limited is 14.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Fineotex Chemical Limited (FCL)?
On an EBIT basis the return on assets of Fineotex Chemical Limited is 21.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Fineotex Chemical Limited (FCL)?
The operating margin of Fineotex Chemical Limited is 12.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Fineotex Chemical Limited (FCL)?
Revenue at Fineotex Chemical Limited is growing +162% versus a year earlier (3y avg +14.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Fineotex Chemical Limited (FCL)?
Earnings per share at Fineotex Chemical Limited are growing +116% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Fineotex Chemical Limited (FCL) generate?
The free cash flow of Fineotex Chemical Limited is −₹476M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Fineotex Chemical Limited (FCL) hold?
Fineotex Chemical Limited holds more cash than debt, ₹380M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Fineotex Chemical Limited in the live analysis
One click puts Fineotex Chemical Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
